# Boston Microfluidics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/boston-microfluidics

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, US
- Website: www.bostonmicrofluidics.com
- Total disclosed funding: $18M
- Latest round: Series A (Aug 26, 2019)
- Investors on record: 2

## About

Boston Microfluidics develops innovative microfluidic technologies that enhance diagnostic capabilities and improve laboratory processes, focusing on precision and efficiency in healthcare diagnostics.Boston Microfluidics specializes in microfluidic technologies that support diagnostic advancements. Founded in Cambridge, US, the company raised USD 17.5 mn in a Series A funding round on August 26, 2019, led by Anzu Partners and LabCorp Ventures. Linh Hoang serves as the CEO.Boston Microfluidics specializes in the development and manufacturing of advanced microfluidic devices that enable precise liquid handling, automate sample testing, and integrate multiple assays into a single platform. Their products are aimed at healthcare providers, research institutions, and pharmaceutical companies, addressing needs in point-of-care diagnostics and high-throughput screening. These technologies allow users to perform complex analyses with minimal sample volumes, thus reducing costs and increasing efficiency, and serve a diverse clientele across North America, Europe, and Asia.Boston Microfluidics generates revenue primarily through direct sales of microfluidic devices and related services to institutional clients such as hospitals and research laboratories. Transactions typically involve structured agreements with clients, which include the purchase of devices along with maintenance and support packages. The company also forms partnerships with larger healthcare organizations, integrating its technology into existing diagnostic workflows. Their pricing structure is reflective of the advanced nature of their products, utilizing tiered pricing plans based on device volume or subscription models for ongoing support and software updates, which helps secure long-term contracts and ensures a stable revenue stream.With the recent Series A funding of USD 17.5 mn raised in August 2019, Boston Microfluidics aims to expand its product line and develop new microfluidic devices tailored for emerging market needs. The company is targeting expansion into European and Asian markets by 2021, with specific plans for product launches that enhance diagnostic capabilities. The funding will support research and development initiatives focused on enhancing product offerings and increasing market reach.

## Funding rounds

- Series A, Aug 26, 2019, $18M — Anzu Partners, LabCorp Ventures

## Investors

- Anzu Partners (https://capitalatlas.ai/funds/anzu-partners) — Series A
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series A